TEZEPELUMAB REDUCED OCS USE IN OCS-DEPENDENT PATIENTS WITH SEVERE ASTHMA: PHASE 3B WAYFINDER INTERIM Results
| Autor: | Jackson, D., Lugogo, N., Gurnell, M., Llanos-Ackert, J., Martin, N., Keeling, N., Salapa, K., Cook, B. |
|---|---|
| Zdroj: | In Annals of Allergy, Asthma & Immunology November 2023 131(5) Supplement 1:S43-S43 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|